Tharimmune, Inc. - Common Stock (THAR) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
THAR on Nasdaq
Shares outstanding
41,917,397
Price per share
$4.05
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
8,074,302
Total reported value
$24,465,138
% of total 13F portfolios
0%
Share change
+6,835,545
Value change
+$20,711,555
Number of holders
22
Price from insider filings
$4.05
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tharimmune, Inc. - Common Stock (THAR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BROADRIDGE FINANCIAL SOLUTIONS, INC. 10% $12,688,270 4,187,548 Broadridge Financial Solutions, Inc. 30 Jan 2026
LCV FUND VIII, L.P. 10% $12,256,129 4,044,927 LCV Fund VIII, L.P. 30 Jan 2026
ARK Investment Management LLC 8.9% $9,853,660 3,252,033 ARK Investment Management LLC 31 Dec 2025
BlackRock, Inc. 2.2% -76% $2,320,462 +$308,899 765,829 +15% BlackRock, Inc. 31 Dec 2025

As of 31 Dec 2025, 22 institutional investors reported holding 8,074,302 shares of Tharimmune, Inc. - Common Stock (THAR). This represents 19% of the company’s total 41,917,397 outstanding shares.

Top 23 Institutional Shareholders

The largest institutional shareholders of Tharimmune, Inc. - Common Stock (THAR) together control 19% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARK Investment Management LLC 7.8% 3,252,033 0.07% $9,853,660
Clear Street Group Inc. 4% 1,671,836 0.03% $5,065,663
BlackRock, Inc. 1.8% 765,829 +15% 0% $2,320,462
VANGUARD GROUP INC 1.4% 586,647 +1166% 0% $1,777,541
Feynman Point Asset Management LLC 1% 433,604 0% 2.6% $1,313,820
MARSHALL WACE, LLP 0.81% 339,789 0% $1,029,561
GEODE CAPITAL MANAGEMENT, LLC 0.8% 335,923 +1103% 0% $1,017,846
BLAIR WILLIAM & CO/IL 0.65% 274,324 0% $831,202
Summit Trail Advisors, LLC 0.23% 95,000 0% $287,850
Aristides Capital LLC 0.2% 83,500 0.09% $253,005
NORTHERN TRUST CORP 0.19% 81,559 0% $247,124
STATE STREET CORP 0.09% 36,621 +109% 0% $110,962
UBS Group AG 0.08% 32,836 +3842% 0% $99,494
Drucker Wealth 3.0, LLC 0.06% 25,337 +150% 0.01% $76,771
FRANKLIN RESOURCES INC 0.06% 25,000 0% 0% $75,750
Garden State Investment Advisory Services LLC 0.04% 15,197 0.01% $46,047
Essex LLC 0.02% 10,155 0.01% $30,770
MORGAN STANLEY 0.01% 5,263 0% $15,947
PNC Financial Services Group, Inc. 0% 2,000 0% 0% $6,060
SBI Securities Co., Ltd. 0% 1,525 0% 0% $4,621
BANK OF AMERICA CORP /DE/ 0% 302 +763% 0% $915
CITIGROUP INC 0% 22 -100% 0% $67
Crewe Advisors LLC 0% 0 -100% $0

Institutional Holders of Tharimmune, Inc. - Common Stock (THAR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 8,074,302 $24,465,138 +$20,711,555 $3.03 22
2025 Q3 805,153 $2,286,635 +$2,019,146 $2.84 12
2025 Q2 102,126 $198,860 +$66,582 $1.94 9
2025 Q1 68,104 $92,621 -$170,640 $1.36 6
2024 Q4 149,093 $303,606 +$252,990 $2.03 10
2024 Q3 24,257 $60,157 +$39,400 $2.46 4
2024 Q2 6,181 $21,819 +$21,819 $3.53 4